我要投票 HYK华因康在基因检测行业中的票数:26
· 外 推 电 报 ·
2024-12-04 01:37:02 星期三

【HYK华因康是哪个国家的品牌?】

HYK华因康是什么牌子?「HYK华因康」是 深圳华因康基因科技有限公司 旗下著名品牌。该品牌发源于广东,由创始人盛司在2008-01-23期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

华因康集团秉承“专业、严谨、创新、服务”的理念,自2008年创立以来,一直致力于中华民族健康事业,发展迅猛。迄今拥有深圳市华因康高通量生物技术研究院、深圳华因康基因科技有限公司、华因康基因检测中心及全国各地多家分支机构,成为以基因技术为核心,拥有雄厚研发支撑、具备研发、生产和应用三位一体的完整产业链的生物技术高科技集团。

研发中心–深圳市华因康高通量生物技术研究院拥有一支在机械、光学、电子、生化、软件、生物信息、生物医疗等技术领域具备尖端技术成果的科学家、教授、博士、博士后及行业专家组成的精英技术团队。研究院面向世界科学前沿和国家战略发展需求,以新型DNA测序分析技术的突破为契机,旨在研究高通量生物技术,开发高通量实验和检测设备,寻找高通量检测新方法,为我国生命科技领域的上游进行产业布局,搭建与基因技术相关的生命科技产业基础性研究平台,进行国际前沿基因组科学基础及应用研究与技术开发,提升我国基因技术自主创新能力。

产品中心-深圳华因康基因科技有限公司专业生产、销售高通量基因测序设备、生物试剂和基因信息分析软件,提供科研技术服务与生物信息数据分析技术服务。公司主导产品PSTAR高通量基因测序系统,填补了我国在生命科技产业核心装备、基因测序设备制造、试剂生产与生物信息分析服务等领域的空白,广泛应用于生命科学基础研究、临床诊断与治疗、疾病预防与保健以及新药研制等领域。

基因检测中心-华因康基因检测中心依托于华因康基因新一代高通量基因测序系统平台技术,是转化医学的专业化服务机构。中心以新一代高通量基因测序系统技术平台为核心,辅以实时荧光PCR平台、STR分析平台、免疫组化、荧光原位杂交等技术平台,覆盖了DNA、RNA、蛋白水平,测序、PCR、蛋白免疫组化、FISH等多种检测技术。已率先研发出多种适用于亚洲人的临床基因检测项目,专业提供“肿瘤个体化用药指导靶基因检测”临床技术服务,同时为临床提供疾病早期筛查、重大疾病分子标志物检测及与保健、优生优育相关的检测服务。与国内顶级医院及科研机构携手,开拓高通量基因测序技术在生命科学与医疗健康领域中的广阔应用,为人类的健康事业提供专业、贴心的个性化服务。

华因康基因(集团)将始终坚持“探索基因信息,提高生命价值”的宗旨,致力于打造基因生命科技在研发、应用、临床转化系统平台技术上的核心竞争力,彰显中国基因产业在世界竞争中的领航者地位,引领中国健康产业发展新方向。


英文翻译:Huayinkang group adheres to the concept of "professional, rigorous, innovative and service". Since its establishment in 2008, it has been committed to the cause of health of the Chinese nation, with rapid development. So far, it has Shenzhen huayinkang high throughput Biotechnology Research Institute, Shenzhen huayinkang Gene Technology Co., Ltd., huayinkang gene testing center and many branches all over the country. It has become a biotechnology high-tech group with gene technology as the core, strong R & D support, and a complete industrial chain of R & D, production and application. R & D Center - Shenzhen huayinkang high throughput Biotechnology Research Institute has an elite technical team composed of scientists, professors, doctors, postdoctors and industry experts with cutting-edge technical achievements in the fields of machinery, optics, electronics, biochemistry, software, biological information, biomedicine and other technical fields. Facing the needs of the world's scientific frontier and national strategic development, and taking the breakthrough of new DNA sequencing analysis technology as an opportunity, the research institute aims to study high-throughput biotechnology, develop high-throughput experiment and detection equipment, find new high-throughput detection methods, make industrial layout for the upstream of China's life science and technology field, and build a basic research platform of life science and technology industry related to gene technology To carry out basic and applied research and technological development of international frontier genomic science and improve the independent innovation ability of China's gene technology. Product Center - Shenzhen huayinkang Gene Technology Co., Ltd. specializes in the production and sales of high-throughput gene sequencing equipment, biological reagents and gene information analysis software, providing scientific research and technical services and biological information data analysis technical services. The company's leading product, pstar high-throughput gene sequencing system, has filled in the gaps in the core equipment of life science and technology industry, gene sequencing equipment manufacturing, reagent production and bio information analysis services in China, and is widely used in basic research of life science, clinical diagnosis and treatment, disease prevention and health care, and new drug development and other fields. Based on the platform technology of new generation high-throughput gene sequencing system of huayinkang gene, huayinkang gene testing center is a professional transformation medicine service organization. The center takes the new generation high-throughput gene sequencing system technology platform as the core, supplemented by real-time fluorescent PCR platform, STR analysis platform, immunohistochemistry, fluorescence in situ hybridization and other technology platforms, covering DNA, RNA, protein level, sequencing, PCR, protein immunohistochemistry, fish and other detection technologies. It has taken the lead in developing a variety of clinical gene detection projects suitable for Asians, providing professional clinical technical services of "tumor individualized drug use guidance target gene detection", and providing early disease screening, detection of major disease molecular markers and detection services related to health care, eugenics and eugenics. Together with the top domestic hospitals and scientific research institutions, we will explore the wide application of high-throughput gene sequencing technology in the field of life science and medical health, and provide professional and intimate personalized services for human health. Huayinkang gene (Group) will always adhere to the tenet of "exploring gene information and improving life value", devote itself to building the core competitiveness of gene life technology in research and development, application and clinical transformation system platform technology, highlight the leading position of China's gene industry in the world competition, and lead the new development direction of China's health industry.

本文链接: https://www.waitui.com/brand/4c1ad289a.html 联系电话:075526611270

千城特选小程序码

7×24h 快讯

名创优品与清华大学经济管理学院携手策划快闪活动

36氪获悉,近日,名创优品与清华大学经济管理学院携手策划了以“与世界 共留名”为主题的校园快闪活动,吸引了数百名清华学子参与。同时,在清华大学的人才宣讲会上,名创优品吸引了近200名来自本科、硕士及博士阶段的学生积极参与,展现了其强大的雇主吸引力。

2小时前

美股大型科技股盘前涨跌不一,苹果涨0.23%

36氪获悉,美股大型科技股盘前涨跌不一,截至发稿,苹果涨0.23%,亚马逊涨0.21%,英伟达涨0.15%,Meta涨0.11%,谷歌涨0.02%,特斯拉跌0.73%,微软跌0.28%,奈飞跌0.12%。

2小时前

热门中概股美股盘前多数上涨,蔚来涨超2%

36氪获悉,热门中概股美股盘前多数上涨,截至发稿,蔚来涨超2%,拼多多涨超1%,小鹏汽车涨0.79%,B站涨0.75%,阿里巴巴涨0.54%,百度涨0.02%,理想汽车跌超1%,京东跌0.43%。

2小时前

上海均价12.9万元/m²的楼盘认购率超700%

11月上海新房市场供应放量。据亿翰智库统计,徐汇滨江板块中海领邸·玖章开盘选房,552套房源认购率约282%,再度触发积分,并刷新上海今年单次认购人数纪录。开盘日光,销售额达到85亿元,也是该项目第四次实现开盘售罄;上海黄浦区露香园·天誉开盘,开盘当日即创下约78亿元销售成绩。(每经网)

2小时前

欧盟委员会呼吁为欧洲电动汽车行业额外提供10亿欧元资金支持

欧盟委员会周二呼吁额外提供10亿欧元的欧盟资金支持电动汽车电池制造,并表示,这将是欧盟创新基金的46亿欧元促进欧盟净零技术和可再生氢拨款的一部分。欧洲电动汽车制造商面临市场竞争,需求低于预期。欧盟专员沃普克·霍克斯特拉(Wopke Hoekstra)在一份声明中表示:“正如所承诺的,我们正在投资46亿欧元以支持欧洲在净零技术、电动汽车电池和可再生氢气方面的尖端项目。”(新浪财经)

2小时前

本页详细列出关于DeepCare的品牌信息,含品牌所属公司介绍,DeepCare所处行业的品牌地位及优势。
咨询